Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 140 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.
Illumina’s technology had purportedly reduced the cost of sequencing a human genome to US$1,000 by 2014. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.
Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee. While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina’s BeadArray technology at Tufts University and negotiated an exclusive license to that technology. In 1999, Illumina acquired Spyder Instruments (founded by Michal Lebl, Richard Houghten, and Jutta Eichler) for their technology of high-throughput synthesis. Illumina completed its initial public offering in July 2000.
Illumina began offering single nucleotide polymorphism (SNP) genotyping services in 2001 and launched its first system, the Illumina BeadLab, in 2002, using GoldenGate Genotyping technology. Illumina currently offers microarray-based products and services for an expanding range of genetic analysis sequencing, including SNP genotyping, gene expression, and protein analysis. Illumina’s technologies are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
The Illumina Agricultural Greater Good Initiative grants launched in 2011, and are awarded annually. This program spurs critically needed research that will increase the sustainability, productivity, and nutritional density of agriculturally important crop and livestock species. Grant recipients receive donations of Illumina products to support their projects.
Benefits
- The Grand Prize winner will receive up to $350,000 of in-kind consumables and/or services at list price value on up to 1000 samples of his/her choice.
Eligibilities
- The grant program is open to basic researchers in Agrigenomics at academic, for profit, or nonprofit institutions.
- Priority will be given to research that increases sustainability, productivity, and nutritional density of the world’s food supply.
Application Process
- Applicants should provide in 400 words or less, a statement of work, and a description of the impact of their research. Applicants may also include up to three figures, with legends, and a list of citations (with 200 word count limit).
In these sections, applicants should include:
- Economic impact
- Social impact
- Collaborators
- Nations represented
- Technologies used
- Other sources of funding
To be considered, all entries must:
- Be in English.
- Be complete.
- Be an original work.
** Applicants should apply through Illumina’s website with all the necessary documents.
Application Deadline: September 30, 2023
Application ClosedOfficial link
